Crossmark

Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study

Crossref DOI link: https://doi.org/10.1186/s13054-021-03628-z

Published Online: 2021-06-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tholén, Maria

Ricksten, Sven-Erik

Lannemyr, Lukas http://orcid.org/0000-0002-8280-5210
Funding

Funding for this research was provided by:

Göteborgs Läkaresällskap (43141, 7771551)

Sahlgrenska Universitetssjukhuset (.)

University of Gothenburg
License Information

Text and Data Mining valid from 2021-06-12

Version of Record valid from 2021-06-12
More Information

Article History

Received: 31 March 2021

Accepted: 6 June 2021

First Online: 12 June 2021

Declarations

:

: The study protocol was approved by the Swedish Ethical Review Authority, Dnr 440-14, date 11/11/2014. Informed consent was obtained from all patients or next of kin before enrollment.

: Not applicable.

: Lukas Lannemyr and Sven-Erik Ricksten have received speaker honorarium from Orion Pharma.

Document is current

Any future updates will be listed below